These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 22563211)
1. Serum elastin-derived peptides and anti-elastin antibody in patients with systemic sclerosis. Hong YJ; Kim J; Oh BR; Lee YJ; Lee EY; Lee EB; Lee SH; Song YW J Korean Med Sci; 2012 May; 27(5):484-8. PubMed ID: 22563211 [TBL] [Abstract][Full Text] [Related]
2. Detection of free elastin-derived peptides among diabetic children. Nicoloff G; Petrova Ch; Christova P; Nikolov A Atherosclerosis; 2007 Jun; 192(2):342-7. PubMed ID: 16996522 [TBL] [Abstract][Full Text] [Related]
3. Increased levels of elastin-derived peptides in cerebrospinal fluid of patients with lacunar stroke. Tzvetanov P; Nicoloff G; Rousseff R; Christova P Clin Neurol Neurosurg; 2008 Mar; 110(3):239-44. PubMed ID: 18093726 [TBL] [Abstract][Full Text] [Related]
4. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis. Nishijima C; Sato S; Takehara K J Rheumatol; 2001 Aug; 28(8):1847-51. PubMed ID: 11508588 [TBL] [Abstract][Full Text] [Related]
5. Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. Costa S; Mondini M; Caneparo V; Afeltra A; Airò P; Bellisai F; Faggioli P; Gerli R; Lotzniker M; Meroni PL; Morozzi G; Radice A; Riccieri V; Scarsi M; Sebastiani GD; Sinico RA; Tincani A; Gariglio M; Landolfo S Rheumatology (Oxford); 2011 Apr; 50(4):674-81. PubMed ID: 21134960 [TBL] [Abstract][Full Text] [Related]
6. Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis. Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K Br J Dermatol; 2004 Oct; 151(4):803-8. PubMed ID: 15491420 [TBL] [Abstract][Full Text] [Related]
7. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis]. Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306 [TBL] [Abstract][Full Text] [Related]
8. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations. Kodera M; Hayakawa I; Komura K; Yanaba K; Hasegawa M; Takehara K; Sato S J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017 [TBL] [Abstract][Full Text] [Related]
10. Abnormal levels of serum anti-elastin antibodies in patients with symptomatic carotid stenosis. Tzvetanov P; Hegde V; Al-Hashel JY; Atanasova M; Sohal AP; Rousseff RT Clin Neurol Neurosurg; 2014 Jan; 116():9-12. PubMed ID: 24388508 [TBL] [Abstract][Full Text] [Related]
11. Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis. Allanore Y; Borderie D; Lemaréchal H; Cherruau B; Ekindjian OG; Kahan A J Rheumatol; 2003 Jan; 30(1):68-73. PubMed ID: 12508392 [TBL] [Abstract][Full Text] [Related]
12. Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis. Stochmal A; Czuwara J; Zaremba M; Rudnicka L Arch Dermatol Res; 2020 Aug; 312(6):453-458. PubMed ID: 31667578 [TBL] [Abstract][Full Text] [Related]
13. Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis. Yazawa N; Kikuchi K; Ihn H; Fujimoto M; Kubo M; Tamaki T; Tamaki K J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):70-5. PubMed ID: 10607322 [TBL] [Abstract][Full Text] [Related]
14. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis. Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328 [TBL] [Abstract][Full Text] [Related]
15. Association of anti phosphatidyl ethanolamine antibodies and low complement levels in systemic sclerosis patients--results of a cross-sectional study. Bălănescu P; Lădaru A; Bălănescu E; Băicuş C; Dan GA Scand J Clin Lab Invest; 2015 Oct; 75(6):476-81. PubMed ID: 26067612 [TBL] [Abstract][Full Text] [Related]
16. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients. D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935 [TBL] [Abstract][Full Text] [Related]
17. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin]. Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902 [TBL] [Abstract][Full Text] [Related]
18. Serum elastin-derived peptides in age-related macular degeneration. Sivaprasad S; Chong NV; Bailey TA Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3046-51. PubMed ID: 16123400 [TBL] [Abstract][Full Text] [Related]
19. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320 [TBL] [Abstract][Full Text] [Related]